The influence of dopaminergic medication on gait automaticity in Parkinson's disease

The Influence of Dopaminergic Medication on Regularity and Determinism of Gait and Balance in Parkinson's Disease: A Pilot Analysis

Background/Objectives: Understanding how dual-tasking and Parkinson's disease medication affect gait and balance regularity can provide valuable insights to patients, caregivers, and clinicians regarding frailty and fall risk. However, dual-task gait and balance studies in PD most often only employ linear measures to describe movement regularity. Some have used nonlinear techniques to analyze PD performances, but only in the on-medication state. Thus, it is unclear how the nonlinear aspects of gait or standing balance are affected by PD medication. This study aimed to assess how dopaminergic medication influenced the regularity and determinism of joint angle and anterior-posterior (AP) and medial-lateral (ML) center of pressure (COP) path time-series data while single- and dual-tasking in PD. Methods: Sixteen subjects with PD completed single- and dual-task gait and standing balance trials for 3 min off and on dopaminergic medication. Sample entropy and percent determinism were calculated for bilateral hip, knee, and shoulder joints, and the AP and ML COP path. Results: There were no relevant medication X task interactions for either the joint angles series or the balance series. Instead, the results supported independent effects of medication, dual-tasking, or standing with eyes closed. Balance task difficulty (i.e., eyes open vs. eyes closed) was detected by the nonlinear analyses, but the nonlinear measures yielded opposing results such that standing with eyes closed simultaneously yielded less regular and more deterministic signals. Conclusions: When juxtaposed with previous findings, these results suggest that medication-induced functional improvements in people with PD might be accompanied by a shift from lesser to greater signal consistency, and the effects of dual-tasking and standing with eyes closed were mixed. Future studies would benefit from including both linear and nonlinear measures to better describe gait and balance performance and signal complexity in people with PD.

Imbalance and Falls in Patients with Parkinson's Disease: Causes and Recent Developments in Training and Sensor-Based Assessment

Imbalance and falls in patients with Parkinson's disease (PD) do not only reduce their quality of life but also their life expectancy. Aging-related symptoms as well as disease-specific motor and non-motor symptoms contribute to these conditions and should be treated when appropriate. In addition to an active lifestyle, advanced exercise training is useful and effective, especially for less medically responsive symptoms such as freezing of gait and postural instability at advanced stages. As treadmill training in non-immersive virtual reality, including dual tasks, significantly reduced the number of falls in PD patients, the mechanism(s) explaining this effect should be further investigated. Such research could help to select the most suitable patients and develop the most effective training protocols based on this novel technology. Real-life digital surrogate markers of mobility, such as those describing aspects of endurance, performance, and the complexity of specific movements, can further improve the quality of mobility assessment using wearables.

Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation

INTRODUCTION

Patients with advanced Parkinson disease (PD) often experience problems with mobility, including walking under single- (ST) and dual-tasking (DT) conditions. The effects of deep brain stimulation in the subthalamic nucleus (DBS) versus dopaminergic medication (Med) on these conditions are not well investigated.

MATERIALS AND METHODS

We used two ST and two DT-gait paradigms to evaluate the effect of DBS and dopaminergic medication on gait parameters in 14 PD patients (mean age 66 ± 8 years) under DBS_OFF/Med_ON, DBS_ON/Med_OFF, and DBS_ON/Med_ON conditions. They performed standardized 20-meter walks with convenient and fast speed. To test DT capabilities, they performed a checking-boxes and a subtraction task during fast-paced walking. Quantitative gait analysis was performed using a tri-axial accelerometer (Dynaport, McRoberts, The Netherlands). Dual-task costs (DTC) of gait parameters and secondary task performance were compared intraindividually between DBS_OFF/Med_ON vs DBS_ON/Med_ON, and DBS_ON/Med_OFF vs DBS_ON/Med_ON to estimate responsiveness.

RESULTS

Dopaminergic medication increased gait speed and cadence at convenient speed. It increased cadence and decreased number of steps at fast speed, and improved DTC of cadence during the checking boxes and DTC of cadence and number of steps during the subtraction tasks. DBS only improved DTC of cadence during the checking boxes and DTC of gait speed during the subtraction task.

CONCLUSION

Dopaminergic medication showed larger additional effects on temporal gait parameters under ST and DT conditions in advanced PD than DBS. These results, after confirmation in independent studies, should be considered in the medical management of advanced PD patients with gait and DT deficits.

Effect of concurrent transcranial direct current stimulation on instrumented timed up and go task performance in people with Parkinson's disease: A double-blind and cross-over study

Transcranial direct current stimulation (tDCS) delivered to the dorsolateral prefrontal cortex (DLPFC) can improve mobility among people with Parkinson's disease (PD). Previous studies suggest that delivering tDCS during task performance might be beneficial. However, only a few studies explored the effect of combining tDCS with task. We investigated the effect of stimulating the DLPFC using anodal tDCS while performing a timed up and go (TUG) test and its sustained effects. In this sham-controlled, cross-over, and double-blind study, twenty participants with PD (age = 67.8 ± 8.3 years and 6 females) completed two sessions (anodal or sham tDCS), conducted in the randomized and counterbalanced manner, with at least a 1-week gap. Stimulation involved transferring 2 mA current through the DLPFC for 30 min. Single-trial of TUG test was performed under single- and dual-task conditions before, during, immediately after, 15 and 30 min after stimulation ceased. We estimated durations of completing different components of TUG. Phoneme verbal fluency task was given as the cognitive distractor during the dual-tasking. An improvement was observed in cognitive performance due to the tDCS condition (d = 0.7, p < 0.01) over time. However, we found no effect of tDCS condition on iTUG related outcomes under single- or dual-task conditions. In conclusion, DLPFC stimulation combined with task improved cognitive performance only, and the improvement was sustained after tDCS ceased. Future studies may investigate stimulating multiple brain regions to improve motor and cognitive performance.

Transcranial direct current stimulation of dorsolateral prefrontal cortex improves dual-task gait performance in patients with Parkinson's disease: A double blind, sham-controlled study

BACKGROUND

Despite advances in pharmacological treatments and surgical processes, the problem of impaired dual-tasking persists in people with Parkinson's disease (PD). Recently, transcranial direct current stimulation (tDCS) applied to the dorsolateral prefrontal cortex (DLPFC) has shown the potential to improve dual-task walking.

RESEARCH QUESTION

Can combining left DLPFC stimulation using tDCS with dual-task performance reduce the cost of dual-tasking in individuals with PD?

METHODS

We conducted a sham-controlled, cross-over, and double-blind study to investigate the effect of combining tDCS with the dual-task walk and its sustained effects among people with PD. Twenty participants with PD completed two sessions (anodal or sham tDCS) with at least a 1-week gap. Stimulation involved transferring 2 mA current through the left DLPFC for 30 min. Single- and dual-task gait was assessed before, during, immediately after, 15, and 30 min after stimulation ceased. Phoneme verbal fluency task was given as the cognitive distractor during dual task.

RESULTS AND CONCLUSION

The results of this study show that in the dual-task condition, participants walked faster at fifteen minutes (p = 0.017) and thirty minutes (p < 0.01) after anodal tDCS ceased compared to sham. Similarly, participants generated a higher number of words per minute at fifteen minutes (p = 0.017), and thirty minutes (p < 0.01) after anodal tDCS ceased compared to sham. Furthermore, the dual-task cost (DTC) associated with gait speed was significantly lower (p = 0.022) at fifteen minutes after anodal tDCS compared to sham tDCS. However, no significant effect of tDCS was observed on gait and cognitive performance under the single-task condition. In conclusion, left DLPFC stimulation can improve dual-tasking in participants with PD and the peaking of the tDCS effect was observed at fifteen minutes after stimulation ceased.

Nordic walking influence on biomechanical parameters: a systematic review

INTRODUCTION

Nordic walking (NW) as a form of physical activity has been shown to have benefits in various domains, but little is known about the effect of NW on more specific biomechanical parameters. The purpose is to determine the impact of NW on the following parameters: walking speed/distance, muscle activation, spatiotemporal parameters, kinematics and ground reaction force.

EVIDENCE ACQUISITION

A literature search was carried out in different databases from October 2008 to October 2018. This review was conducted and reported in accordance with the PRISMA statement. Finally, 42 studies with a median PEDro Score of 5.5/10 were included.

EVIDENCE SYNTHESIS

The included studies reported increased walking distance (+14.8%, P<0.05), walking speed (+25.5%, P<0.05), and stride length (+10.4%, P<0.05), but decreased cadence (-6.2%, P<0.05). NW generally increased: muscle activation and strength for upper limbs; upper and lower limb range of motion, and ground reaction force.

CONCLUSIONS

NW has beneficial effects on many biomechanical parameters. It appears to be an effective way of doing physical activity and could be used in physical rehabilitation or in daily life.

The effects of dual-task in patients with Parkinson's disease performing cognitive-motor paradigms

Patients with Parkinson's disease (PD) exhibit impaired dual-task (DT) performance. A recent meta-analysis confirmed that dual tasking severely affects walking performance in PD patients. However, one report indicated that a cycling DT paradigm has facilitative effects on cognition. We investigated the effects of dual tasking by using walking and cycling as motor tasks and revealed the clinical determinants associated with DT performance. Twenty-seven eligible participants were enrolled for clinical, cognitive-walking, and cognitive-cycling DT paradigm investigations. The mean age and age at onset of the patients were 59.87 ± 6.3 and 53.11 ± 8.4 years, respectively. Both the off- and on-state akinesia subscores were worse on the more-affected side than on the less-affected side. However, the DT effects on the cycling and gait outcomes on both the more-affected and the less-affected side showed no significant differences. The DT effect on the two motor tasks and cognitive performance during a concurrent walking task declined. Nevertheless, the DT effect on cognition improved during cycling. The present study also revealed that the levodopa equivalent daily dosage was highly associated with cognitive-cycling performance and that the akinesia subscore was the most relevant factor that contributed to cognitive-walking performance. In conclusion, DT facilitation or interference might be mediated by the type of motor task applied. The cognitive-cycling DT paradigm had a facilitative effect on cognition. Cycling exercise may diminish motor dysfunction has been investigated. We suggest that cognitive-cycling DT training is a potential adjuvant therapeutic strategy for patients with PD to promote motor and cognitive functions.